Authors:
Hampel, DJ
Sansome, C
Sha, M
Brodsky, S
Lawson, WE
Goligorsky, MS
Citation: Dj. Hampel et al., Toward proteomics in uroscopy: Urinary protein profiles after radiocontrast medium administration, J AM S NEPH, 12(5), 2001, pp. 1026-1035
Authors:
Brodsky, S
Chen, J
Lee, A
Akassoglou, K
Norman, J
Goligorsky, MS
Citation: S. Brodsky et al., Plasmin-dependent and -independent effects of plasminogen activators and inhibitor-1 on ex vivo angiogenesis, AM J P-HEAR, 281(4), 2001, pp. H1784-H1792
Authors:
Chen, J
Brodsky, S
Li, H
Hampel, DJ
Miyata, T
Weinstein, T
Gafter, U
Norman, JT
Fine, LG
Goligorsky, MS
Citation: J. Chen et al., Delayed branching of endothelial capillary-like cords in glycated collagenI is mediated by early induction of PAI-1, AM J P-REN, 281(1), 2001, pp. F71-F80
Authors:
Abassi, Z
Brodsky, S
Gealekman, O
Rubinstein, I
Hoffman, A
Winaver, J
Citation: Z. Abassi et al., Intrarenal expression and distribution of cyclooxygenase isoforms in rats with experimental heart failure, AM J P-REN, 280(1), 2001, pp. F43-F53
Citation: Ms. Goligorsky et al., Endothelial cell dysfunction leading to diabetic nephropathy - Focus on nitric oxide, HYPERTENSIO, 37(2), 2001, pp. 744-748
Authors:
Li, H
Brodsky, S
Basco, M
Romanov, V
De Angelis, DA
Goligorsky, MS
Citation: H. Li et al., Nitric oxide attenuates signal transduction - Possible role in dissociating caveolin-1 scaffold, CIRCUL RES, 88(2), 2001, pp. 229-236
Authors:
Abassi, ZA
Brodsky, S
Karram, T
Dobkin, I
Winaver, J
Hoffman, A
Citation: Za. Abassi et al., Temporal changes in natriuretic and antinatriuretic systems after closure of a large arteriovenous fistula, CARDIO RES, 51(3), 2001, pp. 567-576
Authors:
Brodsky, S
Abassi, Z
Wessale, J
Ramadan, R
Winaver, J
Hoffman, A
Citation: S. Brodsky et al., Effects of A-192621.1, a specific endothelin-B antagonist, on intrarenal hemodynamic responses to endothelin-1, J CARDIO PH, 36, 2000, pp. S311-S313
Authors:
Hayek, T
Attias, J
Coleman, R
Brodsky, S
Smith, J
Breslow, JL
Keidar, S
Citation: T. Hayek et al., The angiotensin-converting enzyme inhibitor, fosinopril, and the angiotensin II receptor antagonist, losartan, inhibit LDL oxidation and attenuate atherosclerosis independent of lowering blood pressure in apolipoprotein E deficient mice, CARDIO RES, 44(3), 1999, pp. 579-587